The National Institute of Allergy and Infectious Diseases (NIAID) intends to publish a Notice of Funding Opportunity (NOFO) to solicit applications for a consortium of Research Centers focused on designing, optimizing, evaluating, and developing broadly protective vaccines for hepatitis C virus (HCV). The goal is to advance vaccine candidates into clinical evaluation. Key aspects of this opportunity include: • Developing broadly protective vaccines for HCV • Designing, optimizing, evaluating, and developing vaccine candidates • Collaborative investigations are encouraged • Estimated funding is $8,300,000 for 4 awards • The opportunity is open to various types of organizations, including independent school districts, public and state-controlled institutions of higher education, native American tribal governments, and non-profits.